Abstract
ObjectiveTo evaluate the long-term safety (up to 3 years) of treatment with pegloticase in patients with refractory chronic gout.MethodsThis open-label extension (OLE) study was conducted at 46 sites in the...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
